Selected Publication:

SHR Neuro Cancer Cardio Lipid Metab Microb

Hoenigl, M; Salmanton-García, J; Walsh, TJ; Nucci, M; Neoh, CF; Jenks, JD; Lackner, M; Sprute, R; Al-Hatmi, AMS; Bassetti, M; Carlesse, F; Freiberger, T; Koehler, P; Lehrnbecher, T; Kumar, A; Prattes, J; Richardson, M; Revankar, S; Slavin, MA; Stemler, J; Spiess, B; Taj-Aldeen, SJ; Warris, A; Woo, PCY; Young, JH; Albus, K; Arenz, D; Arsic-Arsenijevic, V; Bouchara, JP; Chinniah, TR; Chowdhary, A; de, Hoog, GS; Dimopoulos, G; Duarte, RF; Hamal, P; Meis, JF; Mfinanga, S; Queiroz-Telles, F; Patterson, TF; Rahav, G; Rogers, TR; Rotstein, C; Wahyuningsih, R; Seidel, D; Cornely, OA.
Global guideline for the diagnosis and management of rare mould infections: an initiative of the European Confederation of Medical Mycology in cooperation with the International Society for Human and Animal Mycology and the American Society for Microbiology.
Lancet Infect Dis. 2021; 21(8):e246-e257 Doi: 10.1016/S1473-3099(20)30784-2
Web of Science PubMed FullText FullText_MUG

 

Leading authors Med Uni Graz

Hönigl Martin

Co-authors Med Uni Graz

Prattes Jürgen

Altmetrics:

Dimensions Citations:

Plum Analytics:

Scite (citation analytics):

Abstract:

With increasing numbers of patients needing intensive care or who are immunosuppressed, infections caused by moulds other than Aspergillus spp or Mucorales are increasing. Although antifungal prophylaxis has shown effectiveness in preventing many invasive fungal infections, selective pressure has caused an increase of breakthrough infections caused by Fusarium, Lomentospora, and Scedosporium species, as well as by dematiaceous moulds, Rasamsonia, Schizophyllum, Scopulariopsis, Paecilomyces, Penicillium, Talaromyces and Purpureocillium species. Guidance on the complex multidisciplinary management of infections caused by these pathogens has the potential to improve prognosis. Management routes depend on the availability of diagnostic and therapeutic options. The present recommendations are part of the One World-One Guideline initiative to incorporate regional differences in the epidemiology and management of rare mould infections. Experts from 24 countries contributed their knowledge and analysed published evidence on the diagnosis and treatment of rare mould infections. This consensus document intends to provide practical guidance in clinical decision making by engaging physicians and scientists involved in various aspects of clinical management. Moreover, we identify areas of uncertainty and constraints in optimising this management.

Find related publications in this database (using NLM MeSH Indexing)

Animals - administration & dosage

Disease Management - administration & dosage

Fungi - drug effects, genetics, isolation & purification, physiology

Humans - administration & dosage

Mycology - administration & dosage

Mycoses - diagnosis, drug therapy, microbiology

Practice Guidelines as Topic - administration & dosage

Societies, Medical - administration & dosage

© Med Uni Graz • Imprint